Profile_bird

Hey there! msinned is using Twitter.

Twitter is a free service that lets you keep in touch with people through the exchange of quick, frequent answers to one simple question: What's happening? Join today to start receiving msinned's tweets.

Already using Twitter
from your phone? Click here.

msinned

  1. @GSKUS Why has PR about WHO approval for Synflorix gone from global site http://bit.ly/4cfytE - but is on US site? http://bit.ly/2Lomsv 6:04 AM Nov 6th from TweetDeck
  2. RT @pharmagossip: RT @vppharma: True Rumour: AstraZeneca UK to reduce headcount by 40 per cent. Anyone know anything about this?? 9:24 AM Nov 4th from TweetDeck
  3. Eisai's eribulin meets primary overall survival endpoint in Phase III breast cancer study, to file for US/EU approvals http://bit.ly/19upZM 4:34 AM Oct 30th from TweetDeck
  4. Ratiopharm chief is in for the long haul as company bounces back, releases first ever earnings figures http://bit.ly/3I7L8S 2:34 AM Oct 26th from TweetDeck
  5. SuperGen and GlaxoSmithKline enter epigenetic drug discovery collaboration http://bit.ly/2hEHq2 2:26 AM Oct 26th from TweetDeck
  6. Thanks for the RT! @thecortex 6:53 AM Oct 23rd from TweetDeck
  7. MolMed wins patent litigation in Italian court against LTK Farma related to TK therapy http://bit.ly/dTPYi 4:00 AM Oct 23rd from TweetDeck
  8. Diabetes jab better than obesity drug at cutting weight (The Telegraph) http://bit.ly/35GXjG 2:26 AM Oct 23rd from TweetDeck
  9. EC clears Merck & Co.'s proposed acquisition of Schering-Plough http://bit.ly/3kTg5S 1:32 AM Oct 23rd from TweetDeck
  10. Movetis obtains EU approval of Resolor for the treatment of chronic constipation in women, first launch in Q1 2010 1:27 AM Oct 23rd from TweetDeck
  11. Bayer and Onyx target thyroid cancer with initiation of Phase III Nexavar study http://bit.ly/3hhxwG 1:00 AM Oct 23rd from TweetDeck
  12. CHMP issues positive opinion for Boehringer Ingelheim's Micardis to reduce risk of CV morbidity in high-risk patients http://bit.ly/1IawcD 12:59 AM Oct 23rd from TweetDeck
  13. Novartis receives EU approval for Exforge HCT, three-in-one treatment for high blood pressure http://bit.ly/PmGkX 12:57 AM Oct 23rd from TweetDeck
  14. GlaxoSmithKline’s Cervarix wins Japanese approval ahead of Merck & Co./sanofi-aventis' Gardasil http://bit.ly/2KSaJG PR http://bit.ly/3CCQgn 2:06 AM Oct 16th from TweetDeck
  15. Bristol-Myers Squibb cuts 25 percent of Abilify’s sales team - Bloomberg - http://bit.ly/4gb1tH 11:59 PM Oct 15th from TweetDeck
  16. Sosei transfers inflammatory disease compounds, including SD281, to UK company Biocopea http://bit.ly/wMGjR 1:27 AM Oct 14th from TweetDeck
  17. Boehringer Ingelheim receives EC approval for Mirapexin/Sifrol prolonged-release tablets for Parkinson’s disease http://bit.ly/L4din 1:18 AM Oct 14th from TweetDeck
  18. Particularly enjoyed the glass at the end being stamped on! RT @pharmagossip: GSK - Zunrisa ....... Zunseta!: Story http://bit.ly/pCX3G 9:08 AM Oct 13th from TweetDeck
  19. @pharmagossip Sorry, missed link out! http://bit.ly/1lf7A 7:42 AM Oct 13th from TweetDeck
  20. @pharmagossip Now you can write the headline you've always wanted! GSK withdraws marketing application for Zunrisa 7:36 AM Oct 13th from TweetDeck in reply to pharmagossip
  • Name Matt Dennis
  • Location Portsmouth
  • Bio Pharma news researcher, writer and Editor. Part-time boulderer and Tottenham fan!
126 Following 115 Followers 4 Listed
Andy Powrie-Smith Bayer HealthCareNews ThePharmaLetter DIALEDIN.org The Pharma Gateway Biopharmaceuticals HootSuite Jim Edwards Peter D. Loftus cwsampson Pharma Biotech Tech sanofi-aventis TV World Pharma News Shailesh Maingi Jessica Seilheimer Nick Taylor Anne McCrossan amarantoblook Mike Auerbach pharmalot pharmatweetical Scripnews.com Pharma Biotech Tech Pharma Biotech Tech Ian Chamberlain Pharma News PharmaTimes Aniko Lecoultre Boehringer Ingelheim Ellen Licking EuropaBio Josh Berlin Michael McCaughan Chris Morrison Sam Walmsley Denise Silber